[Acute coronary syndrome, stroke, arterial occlusive disease. Bring the patients out of the danger zone!].
作者信息
Füessl H S
出版信息
MMW Fortschr Med. 2004;146 Suppl 1:3.
PMID:15493407
Abstract
摘要
相似文献
1
[Acute coronary syndrome, stroke, arterial occlusive disease. Bring the patients out of the danger zone!].
MMW Fortschr Med. 2004;146 Suppl 1:3.
2
3
[Attack on many vascular fronts. Atherothrombosis trouble seldom comes alone].
MMW Fortschr Med. 2004;146 Suppl 1:4-5.
4
Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
Thromb Haemost. 2008 Mar;99(3):637-9. doi: 10.1160/TH07-07-0465.
5
[Interview with Prof. Dr. H. J. Rupprecht about secondary prevention: what is the optimal thrombocyte function inhibition?].
MMW Fortschr Med. 2004;146 Suppl 1:9-10.
6
Platelet function monitoring in patients with coronary artery disease.
J Am Coll Cardiol. 2007 Nov 6;50(19):1822-34. doi: 10.1016/j.jacc.2007.07.051. Epub 2007 Oct 23.
7
[Prevention of atherothrombotic incidents. CHARISMA Study (The Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance].
Internist (Berl). 2006 Dec;47(12):1295-7. doi: 10.1007/s00108-006-1740-6.
8
Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
Clin Ther. 2008;30 Pt 2:2191-202. doi: 10.1016/j.clinthera.2008.12.001.
9
[Two platelet inhibitors after acute coronary syndrome. Many colleagues are not aware of this].
MMW Fortschr Med. 2002 Mar 28;144(13):50.
10
Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
J Am Coll Cardiol. 2007 Oct 16;50(16):1541-7. doi: 10.1016/j.jacc.2007.05.049. Epub 2007 Oct 1.
Zotero 插件